Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.

Christmann RB, Sampaio-Barros P, Stifano G, Borges CL, de Carvalho CR, Kairalla R, Parra ER, Spira A, Simms R, Capellozzi VL, Lafyatis R.

Arthritis Rheumatol. 2014 Mar;66(3):714-25. doi: 10.1002/art.38288.

2.

Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.

Mendoza FA, Piera-Velazquez S, Farber JL, Feghali-Bostwick C, Jiménez SA.

Arthritis Rheumatol. 2016 Jan;68(1):210-7. doi: 10.1002/art.39421.

3.

Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.

Hoffmann-Vold AM, Aaløkken TM, Lund MB, Garen T, Midtvedt Ø, Brunborg C, Gran JT, Molberg Ø.

Arthritis Rheumatol. 2015 May;67(8):2205-12. doi: 10.1002/art.39166.

4.

Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.

Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O.

Arthritis Rheumatol. 2015 Dec;67(12):3256-61. doi: 10.1002/art.39405.

5.

Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.

Zhang XJ, Bonner A, Hudson M; Canadian Scleroderma Research Group., Baron M, Pope J.

J Rheumatol. 2013 Jun;40(6):850-8. doi: 10.3899/jrheum.120705. Epub 2013 Apr 1.

PMID:
23547215
6.

Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.

Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali-Bostwick CA.

Arthritis Rheum. 2011 Mar;63(3):783-94. doi: 10.1002/art.30159.

7.

Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.

Antoniou KM, Margaritopoulos GA, Goh NS, Karagiannis K, Desai SR, Nicholson AG, Siafakas NM, Coghlan JG, Denton CP, Hansell DM, Wells AU.

Arthritis Rheumatol. 2016 Apr;68(4):1004-12. doi: 10.1002/art.39528.

8.

Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.

Del Galdo F, Sotgia F, de Almeida CJ, Jasmin JF, Musick M, Lisanti MP, Jiménez SA.

Arthritis Rheum. 2008 Sep;58(9):2854-65. doi: 10.1002/art.23791.

9.

Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.

Savarino E, Bazzica M, Zentilin P, Pohl D, Parodi A, Cittadini G, Negrini S, Indiveri F, Tutuian R, Savarino V, Ghio M.

Am J Respir Crit Care Med. 2009 Mar 1;179(5):408-13. doi: 10.1164/rccm.200808-1359OC. Epub 2008 Dec 18.

PMID:
19096004
10.

Interstitial lung disease in systemic sclerosis.

Bussone G, Mouthon L.

Autoimmun Rev. 2011 Mar;10(5):248-55. doi: 10.1016/j.autrev.2010.09.012. Epub 2010 Sep 21. Review.

PMID:
20863911
11.

Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.

Mathai SK, Gulati M, Peng X, Russell TR, Shaw AC, Rubinowitz AN, Murray LA, Siner JM, Antin-Ozerkis DE, Montgomery RR, Reilkoff RA, Bucala RJ, Herzog EL.

Lab Invest. 2010 Jun;90(6):812-23. doi: 10.1038/labinvest.2010.73. Epub 2010 Apr 19.

12.

Molecular network of important genes for systemic sclerosis-related progressive lung fibrosis.

Jiao Y, Chen H, Gu T, Wang L, Postlethwaite A, Gu W.

BMC Res Notes. 2015 Oct 7;8:544. doi: 10.1186/s13104-015-1510-4.

13.

Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.

Lindahl GE, Stock CJ, Shi-Wen X, Leoni P, Sestini P, Howat SL, Bou-Gharios G, Nicholson AG, Denton CP, Grutters JC, Maher TM, Wells AU, Abraham DJ, Renzoni EA.

Respir Res. 2013 Aug 2;14:80. doi: 10.1186/1465-9921-14-80.

14.

CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.

Cai M, Bonella F, He X, Sixt SU, Sarria R, Guzman J, Costabel U.

Respir Med. 2013 Sep;107(9):1444-52. doi: 10.1016/j.rmed.2013.06.004. Epub 2013 Jul 5.

15.
16.

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.

Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, Roth MD, Goldin J, Elashoff R, Seibold JR, Saggar R, Tashkin DP.

Arthritis Rheum. 2011 Oct;63(10):3078-85. doi: 10.1002/art.30467.

17.

Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.

Gonzalez-Lopez L, Rocha-Muñoz AD, Olivas-Flores EM, Garcia-Gonzalez A, Peguero-Gómez AR, Flores-Navarro J, Villa-Manzano AI, Zavaleta-Muñiz SA, Salazar-Paramo M, Mejía M, Juárez-Contreras P, Vazquez-Del Mercado M, Cardona-Muñoz EG, Trujillo-Hernández B, Nava-Zavala AH, Gamez-Nava JI.

Arch Bronconeumol. 2015 Sep;51(9):440-8. doi: 10.1016/j.arbres.2014.06.018. Epub 2014 Oct 7. English, Spanish.

18.

Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.

Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth MD, Elashoff R.

Ann Rheum Dis. 2016 Feb;75(2):374-81. doi: 10.1136/annrheumdis-2014-206076. Epub 2014 Dec 1.

PMID:
25452309
19.

Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.

Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M.

Ann Rheum Dis. 2012 Jun;71(6):1064-72. doi: 10.1136/annrheumdis-2011-200837. Epub 2012 Jan 17.

PMID:
22258486
20.

Decreased sputum caveolin-1 is associated with systemic sclerosis related lung disease.

Yilmaz N, Olgun S, Ahiskali R, Karakurt S, Yavuz S.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):55-61.

PMID:
24751454

Supplemental Content

Support Center